Pathology and tissue sampling protocols for rodent carcinogenicity studies: time for revision.
Drug Safety Evaluation, Pfizer Central Research, Amboise, France. bernard_leblanc@groton.pfizer.com
B
B
Leblanc
D000818:Animals; D015197:Carcinogenicity Tests / Q000592:standards*; D005260:Female; D008297:Male; D009374:Neoplasms, Experimental / Q000473:pathology*; D010336:Pathology / Q000592:standards*; D012377:Rodentia / Q000502:physiology*